Crossmark

Strategies for the enhancement of anti-cancer effect of phosphodiesterase type 5 inhibitors using drug binding fusion proteins

Published Online: 2024-02-13

Published Print: 2024-02

Authors

Kim, Hongbin

Keum, Chang Yeop

Lim, Su Yeon

Lim, Kwang Suk
License Information

Text and Data Mining valid from 2024-02-01

Version of Record valid from 2024-02-01
More Information

Article History

Received: 16 August 2023

Revised: 25 September 2023

Accepted: 27 September 2023

First Online: 13 February 2024

Declarations

:

: The authors declare no conflict of interest.

: Neither ethical approval nor informed consent was required for this study.

Document is current